Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer
James W. Antoon(Tulane University), Barbara S. Beckman(Tulane University)
Cited by 49
Related Papers
Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640
|Endocrinology|2010|114
Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
|Scientific Reports|2012|37